donated to 5 charities from 2020 to 2021 to help the underprivileged
women screened for cervical cancer
reduction in office electricity consumption in 2020
decrease in office paper consumption in 2020
employees engaged in 6 workshops on agile transformation and creative leadership
healthcare professionals trained in areas such as high-medical value marker
patients benefited from novel heart failure diagnosis solution in public hospitals
With a rapidly ageing population and low birth rates, Hong Kong is one of many developed cities working to combat rises in healthcare burdens on an expected leap in the number of seniors.
To alleviate the burden on the public healthcare system, efforts are underway to improve disease awareness and shift public mindsets from reliance on treatment to preventive healthcare.
Roche Diagnostics has been a cornerstone of Hong Kong’s COVID-19 response. At the outset of the pandemic in January 2020, we supplied Hong Kong with its first batch of test kits for emergency screening and worked closely with the Department of Health and 7 Hospital Authority (HA) clusters to kick start their COVID-19 surveillance programme, delivering reagent supplies within 2 weeks.
Advancing Cervical Cancer testing
Ramping up Hong Kong’s COVID-19 testing capacity
A Green Office Overhaul